MIM
IONS icon

MTM Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

MTM Investment Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.5K Hold
258
– – 0.01% 449
2026
Q1 		$19.4K Hold
258
– – 0.01% 439
2025
Q4 		$20.4K Hold
258
– – 0.01% 436
2025
Q3 		$16.9K Hold
258
– – 0.01% 478
2025
Q2 		$10.2K Buy
+258
New +$8.44K ﹤0.01% 537

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

MTM Investment Management's IONS Position: Q2 2026 in Review

MTM Investment Management held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 258 shares worth $20.5K. The position accounts for 0.01% of the portfolio, ranked #449.

MTM Investment Management first reported a position in IONS in Q2 2025 and has held it in 5 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • MTM Investment Management held 258 shares of Ionis Pharmaceuticals worth $20.5K as of Q2 2026.
  • MTM Investment Management left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
  • Ionis Pharmaceuticals made up 0.01% of MTM Investment Management's portfolio in Q2 2026, its #449 holding.
  • MTM Investment Management first reported a position in Ionis Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on MTM Investment Management's 13F filing for Q2 2026, filed 3 Aug 2026.